SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-028101
Filing Date
2018-11-07
Accepted
2018-11-07 17:01:51
Documents
61
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q vktx-10q_20180930.htm 10-Q 2269501
2 EX-10.1 vktx-ex101_80.htm EX-10.1 11278
3 EX-31.1 vktx-ex311_10.htm EX-31.1 20491
4 EX-31.2 vktx-ex312_6.htm EX-31.2 20579
5 EX-32.1 vktx-ex321_7.htm EX-32.1 12870
  Complete submission text file 0001564590-18-028101.txt   8282051

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT vktx-20180930.xml EX-101.INS 1900765
7 XBRL TAXONOMY EXTENSION SCHEMA vktx-20180930.xsd EX-101.SCH 55125
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vktx-20180930_cal.xml EX-101.CAL 38496
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vktx-20180930_def.xml EX-101.DEF 208463
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE vktx-20180930_lab.xml EX-101.LAB 420759
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vktx-20180930_pre.xml EX-101.PRE 333391
Mailing Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130
Business Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130 858-704-4660
Viking Therapeutics, Inc. (Filer) CIK: 0001607678 (see all company filings)

IRS No.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37355 | Film No.: 181167177
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1